Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MARCHEX INC Director's Dealing 2014

Apr 7, 2014

34316_dirs_2014-04-07_9d400609-0e5d-4328-b266-bbd6c7e0511e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MARCHEX INC (MCHX)
CIK: 0001224133
Period of Report: 2014-04-04

Reporting Person: Miller Michael (Sr. VP Acctg & Corp Controller)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-04-07 Class B Common Stock S 5625 $10.0963 Disposed 24875 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-04-04 Restricted Stock Units $ M 30000 Acquired Class B Common Stock (30000) Direct
2014-04-04 Employee Stock Option (right to buy) $10.15 A 30000 Acquired 2024-04-04 Class B Common Stock (30000) Direct

Footnotes

F1: The sales reported on this Form 4 were effected pursuant to a Rule 10(b)5-1 trading plan adopted by the reporting person.

F2: Restricted stock unit award effective April 4, 2014 (the "RSU Grant Date"). Each restricted stock unit represents a contingent right to receive one share of the Corporation's Class B Common Stock in accordance with the following four year vesting schedule: 25% of the total restricted stock units shall vest on each of the first, second, third and fourth annual anniversaries, respectively, of the RSU Grant Date.

F3: Fifty percent (50%) of all options and restricted stock units not already vested as of the date of a Change of Control (as defined in such reporting person's award agreements) shall become immediately vested upon such Change of Control.

F4: Option grant effective April 4, 2014 (the "Option Grant Date"). 25% of the options will vest on the first annual anniversary of the Option Grant Date. Thereafter, 1/12 of the remaining will vest quarterly thereafter for the following three years.

F5: This transaction was executed in multiple trades at prices ranging from $9.78 to $10.38. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, Marchex or a stockholder of Marchex full information regarding the number of shares and prices at which the transaction was effected.